Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness aNd Use of fosleVOdopa-foscarbidopa in Advanced Parkinson Disease in Real Life Setting

NCT06639620 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06639620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06639620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness aNd Use of fosleVOdopa-foscarbidopa in Advanced Parkinson Disease in Real Life Setting
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
November 12, 2024
Completion date
March 31, 2027
Enrollment
250 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

advanced parkinson disease